- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
San Clemente Today
By the People, for the People
Head to Head Comparison: Vyome (HIND) vs. Its Peers
Analyzing the financial performance and market positioning of Vyome and its competitors in the surgical, medical, and dental instruments industry.
Published on Mar. 8, 2026
Got story updates? Submit your updates here. ›
This article provides a detailed comparison of Vyome (NASDAQ:HIND), a publicly-traded company in the 'Surgical, Medical, And Dental Instruments And Supplies' industry, against its 26 industry peers. The analysis covers key metrics such as net margins, return on equity, return on assets, revenue, earnings, valuation, volatility, analyst recommendations, institutional ownership, and insider ownership.
Why it matters
This head-to-head comparison helps investors and industry analysts assess Vyome's competitive positioning and financial performance relative to its industry rivals. It highlights Vyome's strengths and weaknesses compared to its peers, which can inform investment decisions and strategic planning for the company.
The details
The analysis shows that Vyome has a lower price-to-earnings ratio than its rivals, indicating it is more affordable. Vyome also has a stronger consensus rating from analysts and higher potential upside compared to the industry average. Additionally, Vyome has higher institutional and insider ownership, suggesting stronger confidence from major investors. However, Vyome's rivals have higher revenue and lower share price volatility.
- The analysis is based on data as of March 8, 2026.
The players
Vyome
A publicly-traded company in the 'Surgical, Medical, And Dental Instruments And Supplies' industry.
ReShape Lifesciences Inc.
A medical device company that provides products and services to manage and treat obesity and metabolic diseases.
The takeaway
This analysis highlights Vyome's competitive positioning in the surgical, medical, and dental instruments industry. While Vyome faces some challenges compared to its peers, its stronger consensus rating, higher potential upside, and greater institutional and insider ownership suggest it may be a more favorable investment option in the industry.
